Changeflow GovPing Healthcare & Life Sciences USPTO Registration of Accu-Chek Performa Diagno...
Routine Notice Added Final

USPTO Registration of Accu-Chek Performa Diagnostic Test Strips and Blood Glucose Monitors

Favicon for changeflow.com USPTO Trademarks - Medical Devices (Class 010)
Published
Detected
Email

Summary

The USPTO has registered the trademark "Accu-Chek Performa" for diagnostic test strips and blood glucose monitors. This registration covers products used by individuals with diabetes for medical diagnostic purposes and by hospitals. The registration was effective March 20, 2026.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The United States Patent and Trademark Office (USPTO) has officially registered the trademark "Accu-Chek Performa" (TM86075680) for diagnostic test strips and blood glucose monitors. This registration specifically covers diagnostic test strips for glucose level determination, control solutions for quality checks, and blood glucose monitors, all intended for medical diagnostic use by individuals with diabetes and hospitals. The registration was finalized on March 20, 2026.

This is a trademark registration, not a regulatory rule or guidance. It signifies the USPTO's approval of the brand name for specific medical devices. While it does not impose new compliance obligations on regulated entities, it confirms the legal protection of the "Accu-Chek Performa" brand for these products. Companies involved in the distribution or use of these specific diagnostic tools should be aware of this trademark status for branding and intellectual property considerations.

Archived snapshot

Mar 25, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Trademark Applications

ACCU-CHEK PERFORMA

Registered TM86075680 Kind: registered Mar 20, 2026

Abstract

Diagnostic test strips for determining the levels of glucose in blood; control solutions used for quality checks on blood glucose monitors and diagnostic test strips, all for use by individuals with diabetes for medical diagnostic purposes and for use by hospitals; Blood glucose monitors, blood glucose monitoring kit consisting of a blood glucose monitor, diagnostic test strips, lancets and control solutions, all for use by individuals with diabetes for medical diagnostic purposes and for use by hospitals

Filing Date

2013-09-26

View original document →

Get daily alerts for USPTO Trademarks - Medical Devices (Class 010)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 20th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
TM86075680

Who this affects

Applies to
Patients Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical Device Labeling
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Medical Devices Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Trademarks - Medical Devices (Class 010) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!